Complement inhibition: A whole new world
Authors:
Open Access
- 1 April 2026
- journal article
- review article
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 93 (4) , 227-236
Abstract
The complement system is a central component of the innate immune system, and it is a bridge to the adaptive immune system. With this broad functional reach, dysregulation of this system contributes to a wide range of inflammatory and autoimmune conditions. Drugs that inhibit the complement system have dramatically improved outcomes in many previously untreatable diseases, and the number of approved indications is growing rapidly, requiring specialists and generalists alike to be familiar with these drugs.Keywords
This publication has 29 references indexed in Scilit:
- Understanding rare genetic variants within the terminal pathway of complement system in preeclampsiaGenes & Immunity, 2024
- Complement activation and effector pathways in membranous nephropathyKidney International, 2023
- Complement in human disease: approved and up-and-coming therapeuticsThe Lancet, 2023
- Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics2021
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesKidney International, 2021
- Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical managementMolecular Immunology, 2019
- Eculizumab treatment during pregnancy does not affect the complement system activity of the newbornImmunobiology, 2015
- Pathogenesis of the C3 glomerulopathies and reclassification of MPGNNature Reviews Nephrology, 2012
- Complement and its role in innate and adaptive immune responsesCell Research, 2009
- The Immunohistology of IgA NephropathyAmerican Journal of Kidney Diseases, 1988